Cargando…
Cathepsin B inhibition attenuates cardiac dysfunction and remodeling following myocardial infarction by inhibiting the NLRP3 pathway
Autores principales: | Liu, Aiguo, Gao, Xuan, Zhang, Qingbin, Cui, Lianqun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865890/ https://www.ncbi.nlm.nih.gov/pubmed/28944892 http://dx.doi.org/10.3892/mmr.2017.7551 |
Ejemplares similares
-
IL-33 attenuates cardiac remodeling following myocardial infarction via inhibition of the p38 MAPK and NF-κB pathways
por: Yin, Honglei, et al.
Publicado: (2022) -
Sotagliflozin attenuates cardiac dysfunction and remodeling in myocardial infarction rats
por: Zhong, Peng, et al.
Publicado: (2023) -
Inhibition of myocardial cathepsin-L release during reperfusion following myocardial infarction improves cardiac function and reduces infarct size
por: He, Weihong, et al.
Publicado: (2021) -
Retracted: Impact of Yiqi Huoxue Decoction on the Relationship between Remodeling of Cardiac Nerves and Macrophages after Myocardial Infarction in Rats
por: Healthcare Engineering, Journal of
Publicado: (2023) -
Cathepsin A inhibition attenuates myocardial infarction-induced heart failure on the functional and proteomic levels
por: Petrera, Agnese, et al.
Publicado: (2016)